Bariatric surgery in obese patients with type 1 diabetes

Diabetes Care

Volumn 39, Issue 6, 2016, Pages 941-948

  Kirwan, John P ^a   Aminian, Ali ^a   Kashyap, Sangeeta R ^a   Burguera, Bartolome ^a   Brethauer, Stacy A ^a   Schauer, Philip R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; GLUCOSE BLOOD LEVEL;

ACUTE GASTRIC REMNANT DILATION; ADJUSTABLE GASTRIC BANDING; BARIATRIC SURGERY; BILIOPANCREATIC DIVERSION WITH DUODENAL SWITCH; BODY MASS; CARDIOVASCULAR RISK; COMORBIDITY; DIABETIC KETOACIDOSIS; DISEASE SEVERITY; GASTRIC BANDING; GASTROINTESTINAL MOTILITY DISORDER; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; ILEUS; INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; QUALITY OF LIFE; REVIEW; RISK REDUCTION; ROUX Y ANASTOMOSIS; SEX RATIO; SLEEVE GASTRECTOMY; STOMACH BYPASS; SURGICAL TECHNIQUE; WEIGHT REDUCTION; ADULT; ADVERSE EFFECTS; CARDIOVASCULAR DISEASE; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; METABOLISM; POSTOPERATIVE COMPLICATIONS; RISK FACTOR; UTILIZATION;

ADULT; BARIATRIC SURGERY; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 84971222169     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-2732     Document Type: Review

References (73)

1. Daneman D. Type 1 diabetes. Lancet 2006; 367:847-858
2. Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 2010;39:481-497
3. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993;328:1676-1685
4. Laing SP, Swerdlow AJ, Slater SD, et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 2003;46:760-765
5. Dorman JS, Laporte RE, Kuller LH, et al. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes 1984;33:271-276
6. Liu LL, Lawrence JM, Davis C, et al.; SEARCH for Diabetes in Youth Study Group. Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Pediatr Diabetes 2010;11:4-11
7. Chillarón JJ, Flores Le-Roux JA, Benaiges D, Pedro-Botet J. Type 1 diabetes, metabolic syndrome and cardiovascular risk. Metabolism 2014;63:181-187
8. Price SA, Gorelik A, Fourlanos S, Colman PG, Wentworth JM. Obesity is associated with retinopathy and macrovascular disease in type 1 diabetes. Obes Res Clin Pract 2014;8:e178-e182
9. Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC. Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 2004;47:1661-1667
10. Couper JJ, Beresford S, Hirte C, et al. Weight gain in early life predicts risk of islet autoimmunity in children with a first-degree relative with type 1 diabetes. Diabetes Care 2009;32:94-99
11. Franck M, Paquot N, Scheen AJ. [Influence of body weight on the natural history of and the therapeutic approaches to type 1 diabetes]. Rev Med Liege 2012;67:461-467
12. Cohen R. Comment on: Should metabolic surgery be offered in morbidly obese patients with type I diabetes? Surg Obes Relat Dis 2015;11:805-807
13. De Block CE, De Leeuw IH, Van Gaal LF. Impact of overweight on chronic microvascular complications in type 1 diabetic patients. Diabetes Care 2005;28:1649-1655
14. Polsky S, Ellis SL. Obesity, insulin resistance, and type 1 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 2015;22:277-282
15. Burchardt P, Zawada A, Tabaczewski P, et al. Metformin added to intensive insulin therapy reduces plasma levels of glycated but not oxidized low-density lipoprotein in young patients with type 1 diabetes and obesity in comparison with insulin alone: a pilot study. Pol Arch Med Wewn 2013;123:526-532
16. Vella S, Buetow L, Royle P, Livingstone S, Colhoun HM, Petrie JR. The use of metformin in type 1 diabetes: a systematic review of efficacy. Diabetologia 2010;53:809-820
17. Sarkar G, Alattar M, Brown RJ, Quon MJ, Harlan DM, Rother KI. Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes. Diabetes Care 2014;37:666-670
18. Perkins BA, Cherney DZ, Partridge H, et al. Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial. Diabetes Care 2014;37:1480-1483
19. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122:248-256.e5
20. Sjöström L, Lindroos AK, Peltonen M, et al.; Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-2693
21. Aminian A, Zelisko A, Kirwan JP, Brethauer SA, Schauer PR. Exploring the impact of bariatric surgery on high density lipoprotein. Surg Obes Relat Dis 2015;11:238-247
22. Schauer PR, Bhatt DL, Kirwan JP, et al.; STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med 2014;370: 2002-2013
23. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012;366:1577-1585
24. Ikramuddin S, Korner J, Lee WJ, et al. Rouxen-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA 2013;309:2240-2249
25. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008;299:316-323
26. Adams TD, Davidson LE, Litwin SE, et al. Health benefits of gastric bypass surgery after 6 years. JAMA 2012;308:1122-1131
27. Brethauer SA, Aminian A, Romero-Talamás H, et al. Can diabetes be surgically cured? Longterm metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg 2013;258:628-636; discussion 636-637
28. Aminian A, Daigle CR, Romero-Talamás H, et al. Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass. Surg Obes Relat Dis 2014;10:576-582
29. Lannoo M, Dillemans B, Van Nieuwenhove Y, et al. Bariatric surgery induces weight loss but does not improve glycemic control in patients with type 1 diabetes. Diabetes Care 2014;37: e173-e174
30. Brethauer SA, Aminian A, Rosenthal RJ, Kirwan JP, Kashyap SR, Schauer PR. Bariatric surgery improves the metabolic profile of morbidly obese patients with type 1 diabetes. Diabetes Care 2014;37:e51-e52
31. Robert M, Belanger P, Hould FS, Marceau S, Tchernof A, Biertho L. Should metabolic surgery be offered in morbidly obese patients with type I diabetes? Surg Obes Relat Dis 2015;11: 798-805
32. Maraka S, Kudva YC, Kellogg TA, Collazo-Clavell ML, Mundi MS. Bariatric surgery and diabetes: Implications of type 1 versus insulinrequiring type 2. Obesity (Silver Spring) 2015; 23:552-557
33. Middelbeek RJ, James-Todd T, Cavallerano JD, Schlossman DK, Patti ME, Brown FM. Gastric bypass surgery in severely obese women with type 1 diabetes: Anthropometric and cardiometabolic effects at 1 and 5 years postsurgery. Diabetes Care 2015;38:e104-e105
34. Smith BR, Hinojosa MW, Reavis KM, Nguyen NT. Remission of diabetes after laparoscopic gastric bypass. Am Surg 2008;74:948-952
35. Blanco J, Jiménez A, Casamitjana R, et al. Relevance of beta-cell function for improved glycemic control after gastric bypass surgery. Surg Obes Relat Dis 2014;10:9-13; quiz 189-190
36. Tang A, Milner K-L, Tonks K, Campbell LV, Greenfield JR. Comment on Brethauer et al. Bariatric surgery improves the metabolic profile of morbidly obese patients with type 1 diabetes. Diabetes Care 2014;37:e51-e52 (Letter).
37. Diabetes Care 2014;37:e248-e249
38. Raab H, Weiner RA, Frenken M, Rett K, Weiner S. Obesity and metabolic surgery in type 1 diabetes mellitus. Nutr Hosp 2013; 28(Suppl. 2):31-34
39. Garciacaballero M, Martínez-Moreno JM, Toval JA, et al. Improvement of C peptide zero BMI 24-34 diabetic patients after tailored one anastomosis gastric bypass (BAGUA). Nutr Hosp 2013;28(Suppl. 2):35-46
40. Czupryniak L, Wiszniewski M, Szymański D, Pawlłowski M, Loba J, Strzelczyk J. Long-term results of gastric bypass surgery in morbidly obese type 1 diabetes patients. Obes Surg 2010;20: 506-508
41. Mendez CE, Tanenberg RJ, Pories W. Outcomes of Roux-en-Y gastric bypass surgery for severely obese patients with type 1 diabetes: a case series report. Diabetes Metab Syndr Obes 2010;3:281-283
42. Fuertes-Zamorano N, Sánchez-Pernaute A, Torres García AJ, Rubio Herrera MA. Bariatric surgery in type 1 diabetes mellitus; long-term experience in two cases. Nutr Hosp 2013;28: 1333-1336
43. Dirksen C, Jacobsen SH, Bojsen-Møller KN, et al. Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report. Obes Res Clin Pract 2013;7:e269-e274
44. Chuang J, Zeller MH, Inge T, Crimmins N. Bariatric surgery for severe obesity in two adolescents with type 1 diabetes. Pediatrics 2013; 132:e1031-e1034
45. Reyes Garcia R, Romero Muñoz M, Galbis Verdú H. Bariatric surgery in type 1 diabetes. Endocrinol Nutr 2013;60:46-47
46. Ziemiański P, Lisik W, Marszalłek RJ, et al. Improvement of graft function following Rouxen-Y gastric bypass surgery in a morbidly obese kidney recipient: a case report and literature review. Ann Transplant 2014;19:639-642
47. CzupryniakL,StrzelczykJ,CyprykK,etal.Gastric bypass surgery in severely obese type 1 diabetic patients. Diabetes Care 2004;27:2561-2562
48. Dixon JB, Zimmet P, Alberti KG, Rubino F; International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese type 2 diabetes. Surg Obes Relat Dis 2011;7:433-447
49. Deitel M. Update: Why diabetes does not resolve in some patients after bariatric surgery. Obes Surg 2011;21:794-796
50. Aminian A, Brethauer SA, Kirwan JP, Kashyap SR, Burguera B, Schauer PR. How safe is metabolic/diabetes surgery? Diabetes Obes Metab 2015;17:198-201
51. Kirwan JP, Brethauer SA, Aminian A, Rosenthal RJ, Kashyap SR, Schauer PR. Response to comments on Brethauer et al. Bariatric surgery improves the metabolic profile of morbidly obese patients with type 1 diabetes. Diabetes care 2014; 37:e51-e52.
52. Diabetes Care 2014;37:e251
53. Romero-Talamás H, Aminian A, Corcelles R, Fernandez AP, Schauer PR, Brethauer S. Psoriasis improvement after bariatric surgery. Surg Obes Relat Dis 2014;10:1155-1159
54. Romero-Talamás H, Daigle CR, Aminian A, Corcelles R, Brethauer SA, Schauer PR. The effect of bariatric surgery on gout: a comparative study. Surg Obes Relat Dis 2014;10:1161-1165
55. Aminian A, Brethauer SA, Sharafkhah M, Schauer PR. Development of a sleeve gastrectomy risk calculator. Surg Obes Relat Dis 2015; 11:758-764
56. Longitudinal Assessment of Bariatric Surgery (LABS) Consortium; Flum DR, Belle SH, King WC, et al.;. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009;361:445-454
57. Aminian A, Jamal MH, Andalib A, et al. Is laparoscopic bariatric surgery a safe option in extremely high-risk morbidly obese patients? J Laparoendosc Adv Surg Tech A 2015;25:707-711
58. Middelbeek RJ, James-Todd T, Patti ME, Brown FM. Short-term insulin requirements following gastric bypass surgery in severely obese women with type 1 diabetes. Obes Surg 2014; 24:1442-1446
59. Aminian A, Kashyap SR, Burguera B, et al. The incidence and clinical features of diabetic ketoacidosis after bariatric and metabolic surgery. Diabetes Care. 28 January 2016 [Epub ahead of print]. DOI: 10.2337/dc15-2647
60. Han SH, White S, Patel K, Dutson E, Gracia C, Mehran A. Acute gastric remnant dilation after laparoscopic Roux-en-Y gastric bypass operation in long-standing type I diabetic patient: case report and literature review. Surg Obes Relat Dis 2006;2:664-666
61. Hussain A, Mahmood H, El-Hasani S. Can Roux-en-Y gastric bypass provide a lifelong solution for diabetes mellitus? Can J Surg 2009;52: E269-E275
62. Zimmet PZ, Tuomi T, Mackay IR, et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 1994;11: 299-303
63. Lindqvist A, Spégel P, Ekelund M, et al. Gastric bypass improves β-cell function and increases β-cell mass in a porcine model. Diabetes 2014;63: 1665-1671
64. Kashyap SR, Daud S, Kelly KR, et al. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes 2010;34: 462-471
65. Dixon JB, le Roux CW, Rubino F, Zimmet P. Bariatric surgery for type 2 diabetes. Lancet 2012;379:2300-2311
66. Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 2010;61:393-411
67. Thaler JP, Cummings DE. Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009;150:2518-2525
68. Laferrère B. Diabetes remission after bariatric surgery: is it just the incretins? Int J Obes 2011;35(Suppl. 3):S22-S25
69. Aminian A, Jamal M, Augustin T, et al. Failed surgical weight loss does not necessarily mean failed metabolic effects. Diabetes Technol Ther 2015;17:682-684
70. Kielgast U, Krarup T, Holst JJ, Madsbad S. Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function. Diabetes Care 2011;34:1463-1468
71. Breen DM, Rasmussen BA, Kokorovic A, Wang R, Cheung GW, Lam TK. Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nat Med 2012;18:950-955
72. Conway B, Miller RG, Costacou T, et al. Adiposity and mortality in type 1 diabetes. Int J Obes 2009;33:796-805
73. American Diabetes Association. Approaches to glycemic treatment. Sec. 7. In Standards of Medical Care in Diabetesd2015. Diabetes Care 2015;38(Suppl. 1):S41-S48